Stay updated on Tiara™ Mitral Valve System Clinical Trial

Sign up to get notified when there's something new on the Tiara™ Mitral Valve System Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiara™ Mitral Valve System Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T15:30:21.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating access is blocked. A Home link is provided to navigate back to the main ClinicalTrials.gov site.
    Difference
    18%
    Check dated 2026-09-22T22:10:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This is a frontend/software update to the page rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T22:06:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling a new version of the study record.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:29.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page displays a new site revision number (v3.6.5) replacing the prior v3.6.4, signaling a small system/UI update without changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-11T15:23:29.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Outcome timing and follow-up have been expanded to include longer-term assessments up to five years and interim intervals (30, 90, 180 days), with an updated window from implant to follow-up extending to 45 days. New endpoints and measures have been added or clarified, including 6MWT, KCCQ, NYHA, and explicit reporting of device/procedure‑related adverse events and subjects alive and not hospitalized.
    Difference
    1%
    Check dated 2026-07-28T05:59:49.000Z thumbnail image

Stay in the know with updates to Tiara™ Mitral Valve System Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiara™ Mitral Valve System Clinical Trial page.